Out of the lab and into the bathroom: evening short-term exposure to conventional light suppresses melatonin and increases alertness perception.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 3588003)

Published in Int J Mol Sci on January 28, 2013

Authors

Amely Wahnschaffe1, Sven Haedel, Andrea Rodenbeck, Claudia Stoll, Horst Rudolph, Ruslan Kozakov, Heinz Schoepp, Dieter Kunz

Author Affiliations

1: Institute of Physiology, Charité-Universitätsmedizin Berlin (CBF), 10115 Berlin, Germany. amely.wahnschaffe@charite.de.

Articles cited by this

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res (1989) 57.78

Impact of sleep debt on metabolic and endocrine function. Lancet (1999) 14.89

A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol (1976) 11.56

Interacting molecular loops in the mammalian circadian clock. Science (2000) 6.90

Novel melatonin-based therapies: potential advances in the treatment of major depression. Lancet (2011) 5.40

Temporal organization: reflections of a Darwinian clock-watcher. Annu Rev Physiol (1993) 5.20

Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci (2001) 4.36

A novel human opsin in the inner retina. J Neurosci (2000) 4.30

The economic cost of brain disorders in Europe. Eur J Neurol (2012) 3.53

Light suppresses melatonin secretion in humans. Science (1980) 3.45

An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans. J Physiol (2001) 3.34

Suppression of melatonin secretion in some blind patients by exposure to bright light. N Engl J Med (1995) 3.08

Short-wavelength sensitivity for the direct effects of light on alertness, vigilance, and the waking electroencephalogram in humans. Sleep (2006) 2.94

Circadian temperature and melatonin rhythms, sleep, and neurobehavioral function in humans living on a 20-h day. Am J Physiol (1999) 2.60

High sensitivity of human melatonin, alertness, thermoregulation, and heart rate to short wavelength light. J Clin Endocrinol Metab (2004) 2.49

Bright light treatment in elderly patients with nonseasonal major depressive disorder: a randomized placebo-controlled trial. Arch Gen Psychiatry (2011) 2.45

Epidemiological and clinical relevance of insomnia diagnosis algorithms according to the DSM-IV and the International Classification of Sleep Disorders (ICSD). Sleep Med (2009) 2.40

Increased risk of ischaemic heart disease in shift workers. Lancet (1986) 2.33

The effects of prior light history on the suppression of melatonin by light in humans. J Pineal Res (2002) 2.18

Daytime light exposure dynamically enhances brain responses. Curr Biol (2006) 2.17

Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA (2008) 2.07

Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases. Environ Health Perspect (2007) 2.07

Molecular insights into human daily behavior. Proc Natl Acad Sci U S A (2008) 2.03

Chronic jet-lag increases mortality in aged mice. Curr Biol (2006) 2.01

Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry (1997) 1.71

The circadian basis of winter depression. Proc Natl Acad Sci U S A (2006) 1.69

Complex interaction of the sleep-wake cycle and circadian phase modulates mood in healthy subjects. Arch Gen Psychiatry (1997) 1.64

Reduction of scale invariance of activity fluctuations with aging and Alzheimer's disease: Involvement of the circadian pacemaker. Proc Natl Acad Sci U S A (2009) 1.59

Phase relationships between sleep-wake cycle and underlying circadian rhythms in Morningness-Eveningness. J Biol Rhythms (2004) 1.44

Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. J Clin Endocrinol Metab (2010) 1.43

The spectral composition of evening light and individual differences in the suppression of melatonin and delay of sleep in humans. J Pineal Res (2011) 1.28

Alleviation of sleep maintenance insomnia with timed exposure to bright light. J Am Geriatr Soc (1993) 1.23

A "melanopic" spectral efficiency function predicts the sensitivity of melanopsin photoreceptors to polychromatic lights. J Biol Rhythms (2011) 1.21

Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels? Br J Cancer (2004) 1.18

Wavelength-dependent effects of evening light exposure on sleep architecture and sleep EEG power density in men. Am J Physiol Regul Integr Comp Physiol (2006) 1.14

Light-induced melatonin suppression: age-related reduction in response to short wavelength light. Exp Gerontol (2005) 1.12

Melatonin rhythmicity: effect of age and Alzheimer's disease. Exp Gerontol (2003) 1.10

Evening exposure to blue light stimulates the expression of the clock gene PER2 in humans. Eur J Neurosci (2006) 1.08

Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes. Neurotox Res (2012) 1.04

Risk of breast cancer after night- and shift work: current evidence and ongoing studies in Denmark. Cancer Causes Control (2006) 1.02

Nocturnal cortisol and melatonin secretion in primary insomnia. Psychiatry Res (2002) 0.98

Normative data on the daily profile of urinary 6-sulfatoxymelatonin in healthy subjects between the ages of 20 and 84. Psychoneuroendocrinology (2006) 0.97

Nocturnal plasma melatonin levels in patients suffering from chronic primary insomnia. J Pineal Res (1995) 0.94

Circadian effectiveness of two polychromatic lights in suppressing human nocturnal melatonin. Neurosci Lett (2006) 0.93

Neurobiology: bright blue times. Nature (2005) 0.92

Circadian rhythms in mammalian neurotransmitter receptors. Prog Neurobiol (1987) 0.92

Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment. Aging Dis (2011) 0.92

The association between the nocturnal sleep gate and nocturnal onset of urinary 6-sulfatoxymelatonin. J Biol Rhythms (1993) 0.90

Alterations of circadian rhythmicity and sleep in aging: endocrine consequences. Horm Res (1998) 0.88

Pineal calcification in Alzheimer's disease: an in vivo study using computed tomography. Neurobiol Aging (2006) 0.88

Photopic and scotopic light detection in patients with seasonal affective disorder and control subjects. Biol Psychiatry (1999) 0.85

Photoreception for circadian, neuroendocrine, and neurobehavioral regulation. J Physiol Anthropol (2007) 0.83

Effects on subjective and objective alertness and sleep in response to evening light exposure in older subjects. Behav Brain Res (2011) 0.82

Nocturnal melatonin secretion and its modification by treatment in patients with sleep disorders. Adv Exp Med Biol (1999) 0.79

Melatonin: nature's soporific? J Sleep Res (1996) 0.79

Chronobiotic protocol and circadian sleep propensity index: new tools for clinical routine and research on melatonin and sleep. Pharmacopsychiatry (2004) 0.77

Lithium decreases retinal sensitivity, but this is not cumulative with years of treatment. Biol Psychiatry (1997) 0.76

Articles by these authors

Molecular insights into human daily behavior. Proc Natl Acad Sci U S A (2008) 2.03

Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) (2005) 1.77

Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol (2013) 1.71

An E-health solution for automatic sleep classification according to Rechtschaffen and Kales: validation study of the Somnolyzer 24 x 7 utilizing the Siesta database. Neuropsychobiology (2005) 1.71

Examining the gateway to the limbic system with diffusion tensor imaging: the perforant pathway in dementia. Neuroimage (2005) 1.16

Krüppel-like factor 9 is a circadian transcription factor in human epidermis that controls proliferation of keratinocytes. Proc Natl Acad Sci U S A (2012) 1.12

Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology (Berl) (2004) 1.09

The functional Val158Met polymorphism of COMT predicts interindividual differences in brain alpha oscillations in young men. J Neurosci (2009) 1.05

Prostaglandin D synthase (beta-trace) in healthy human sleep. Sleep (2004) 0.99

Nocturnal cortisol and melatonin secretion in primary insomnia. Psychiatry Res (2002) 0.98

Obstructive sleep apnea: Plasma endothelin-1 precursor but not endothelin-1 levels are elevated and decline with nasal continuous positive airway pressure. Peptides (2005) 0.97

Perception of sleep: subjective versus objective sleep parameters in patients with Parkinson's disease in comparison with healthy elderly controls. Sleep perception in Parkinson's disease and controls. J Neurol (2005) 0.97

Normative data on the daily profile of urinary 6-sulfatoxymelatonin in healthy subjects between the ages of 20 and 84. Psychoneuroendocrinology (2006) 0.97

Peripheral lipopolysaccharide administration transiently affects expression of brain-derived neurotrophic factor, corticotropin and proopiomelanocortin in mouse brain. Neurosci Lett (2007) 0.94

Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia. Psychopharmacology (Berl) (2006) 0.93

The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects. Psychopharmacology (Berl) (2006) 0.90

Degree of pineal calcification (DOC) is associated with polysomnographic sleep measures in primary insomnia patients. Sleep Med (2008) 0.89

Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: a placebo-controlled pilot study. Arch Gerontol Geriatr (2006) 0.89

Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: a randomized, controlled, crossover trial of 12 healthy male subjects. J Clin Psychiatry (2005) 0.88

Pineal calcification in Alzheimer's disease: an in vivo study using computed tomography. Neurobiol Aging (2006) 0.88

Impaired sleep quality and sleep duration in smokers-results from the German Multicenter Study on Nicotine Dependence. Addict Biol (2012) 0.87

Melatonin treatment of day-night rhythm disturbances and sundowning in Alzheimer disease: an open-label pilot study using actigraphy. J Clin Psychopharmacol (2004) 0.87

Melatonin excretion levels and polysomnographic sleep parameters in healthy subjects and patients with sleep-related disturbances. Sleep Med (2007) 0.84

Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects. Psychopharmacology (Berl) (2004) 0.84

How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depression. J Clin Psychopharmacol (2002) 0.83

Sludge as a potential important source of antibiotic resistance genes in both the bacterial and bacteriophage fractions. Environ Sci Technol (2014) 0.82

Tolerability of hypnosedatives in older patients. Drugs Aging (2002) 0.82

Polysomnographic findings in five adult patients with pituitary insufficiency before and after cessation of human growth hormone replacement therapy. Clin Endocrinol (Oxf) (2002) 0.82

Narcolepsy increased L-PGDS (beta-trace) levels correlate with excessive daytime sleepiness but not with cataplexy. J Neurol (2005) 0.82

Uremic restless legs syndrome (RLS) and sleep quality in patients with end-stage renal disease on hemodialysis: potential role of homocysteine and parathyroid hormone. Kidney Blood Press Res (2013) 0.81

Declarative memory consolidation during the first night in a sleep lab: the role of REM sleep and cortisol. Psychoneuroendocrinology (2012) 0.80

Serotonin syndrome with tramadol and citalopram. Am J Psychiatry (2004) 0.80

Nocturnal urinary dopamine excretion is reduced in otherwise healthy subjects with periodic leg movements in sleep. Neurosci Lett (2004) 0.79

Modafinil in the treatment of idiopathic hypersomnia without long sleep time--a randomized, double-blind, placebo-controlled study. J Sleep Res (2014) 0.78

Expression of pancreatitis-associated protein after traumatic brain injury: a mechanism potentially contributing to neuroprotection in human brain. Cell Mol Neurobiol (2011) 0.78

Dechlorination and organohalide-respiring bacteria dynamics in sediment samples of the Yangtze Three Gorges Reservoir. Environ Sci Pollut Res Int (2013) 0.78

Catalogue of knowledge and skills for sleep medicine. J Sleep Res (2013) 0.77

Melatonin in rapid eye movement sleep behavior disorder: why does it work? Sleep Med (2013) 0.76

Effect of chloroethene concentrations and granular activated carbon on reductive dechlorination rates and growth of Dehalococcoides spp. Bioresour Technol (2011) 0.76

Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease. Brain Res (2005) 0.76

Ziprasidone decreases cortisol excretion in healthy subjects. Br J Clin Pharmacol (2005) 0.75

Blue-Enriched Morning Light as a Countermeasure to Light at the Wrong Time: Effects on Cognition, Sleepiness, Sleep, and Circadian Phase. Neuropsychobiology (2017) 0.75